The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.
Strupp
Michael
M
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D001682:Biological Availability; D002490:Central Nervous System / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002985:Clinical Protocols / Q000592:standards; D006801:Humans; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D000893:Anti-Inflammatory Agents; D011241:Prednisone; D008775:Methylprednisolone